Shifting the lines against central nervous system disorders
Home
Theranexus
Back
Mission
Management
Governance
Partners
Platform and products
Back
Platform
Drug candidates
THN102
THN201
THN101
Intellectual property
News
Back
Press releases
Upcoming events
Shareholders
Back
Stock Exchange
Documents
Financial Calendar
General Meetings
Investor Contact
Broadcast Alert
Contact
Platform
Drug candidates
THN102
THN201
THN101
Intellectual property
« 3 drug candidates in just 4 years »
> Drug candidates
